The 68Ga‐NOTA‐exendin‐4 PET‐CT technique leverages the GLP‐1 receptor agonist exenatide, which is radiolabeled with 68Ga, to visualize an abnormal concentration of radioactivity in the tumor region of patients with insulinoma. The gene discussed is GLP1R; the disease is neoplasm.